Lymph Node Metastases from Laryngeal and Pharyngeal Carcinomas: Calculation of Burden of Metastasis and its Impact on Prognosis

References

• Lederman M. Radiation therapy in cancer of the larynx. JAMA 1972; 221: 1253–4.
   PubMed Web of Science ®Google Scholar
• Lederman M, Whall MA. Cancer of the larynx. II. The technique of radiation treatment. Br J Radiol 1971; 44: 578–89.
   PubMed Web of Science ®Google Scholar
• Lederman M, Mould RF. Radiation treatment of cancer of the pharynx: with special reference to telecobalt therapy. Br J Radiol 1968; 41: 251–74.
   PubMed Web of Science ®Google Scholar
• Lederman M. Cancer of the pharynx. A study based on 2417 cases with special reference to radiation treatment. J Laryngol Otol 1967; 81: 151–72.
   Google Scholar
• Turner SL, Tiver KW. Radical radiotherapy for carcinoma of the larynx: Westmead Hospital experience. Australas Radiol 1991; 35: 242–7.
   PubMedGoogle Scholar
• Lindberg RD, Fletcher GH. The role of irradiation in the management of head and neck cancer: analysis of results and causes of failure. Tumori 1978; 64: 313–25.
   PubMed Web of Science ®Google Scholar
• Flynn MB, Jesse RH, Lindberg RD. Surgery and irradiation in the treatment of squamous cell cancer of the supraglottic larynx. Am J Surg 1972; 124: 477–81.
   Google Scholar
• Overgaard J, Hansen HS, Andersen AP, et al. Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study. Int J Radiat Oncol Biol Phys 1989; 16: 1065–8.
   PubMed Web of Science ®Google Scholar
• Overgaard J, Hansen HS, Lindelov B, et al. Nimorazole as a hypoxic radiosensitizer in the treatment of supraglottic larynx and pharynx carcinoma. First report from the Danish Head and Neck Cancer Study (DAHANCA) protocol 5–85. Radio-ther Oncol 1991; Suppl 20: 143–9.
   Google Scholar
• Overgaard J, Hansen HS, Sapru W, et al. Conventional radiotherapy as primary treatment of squamous cell car-cinoma of the head and neck. A randomized multicenter study of 5 versus 6 fractions per week-Report from the DAHANCA 7 trial. In press.
   Google Scholar
• Jaulerry C, Dubray B, Brunin F, et al. Prognostic value of tumor regression during radiotherapy for head and neck cancer: a prospective study. Int J Radiat Oncol Biol Phys 1995; 33: 271–9.
   PubMed Web of Science ®Google Scholar
• Johansen J, Christensen PH, Jorgensen K, Andersen JE. Epidermoid carcinoma of the pharynx. Therapeutic results in a series of 221 patients. Acta Oncol 1991; 30: 33–7.
   Google Scholar
• International Union Against Cancer. Harmer MH, ed. TNM classification of malignant tumors. 3rd ed. Berlin: Springer-Verlag, 1978.
   Google Scholar
• International Union Against Cancer. Hermanek P, Sobin LH, eds. TNM classification of malignant tumors. 4th ed. Berlin: Springer-Verlag, 1992.
   Google Scholar
• Overgaard J, Hansen HS, Jorgensen K, Hjelm Hansen M. Primary radiotherapy of larynx and pharynx carcinoma: an analysis of some factors influencing local control and survival. Int J Radiat Oncol Biol Phys 1986; 12: 515–21.
   Google Scholar
• Overgaard J, Hjelm Hansen M, Johansen LV, Andersen AP. Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx. Acta Oncol 1988; 27: 147–52.
   PubMed Web of Science ®Google Scholar
• Cox DR. Regression models and life tables. J R Stat Soc 1972; B34: 187–220.
   Google Scholar
• Fletcher GH, Lindberg RD, Hamberger A, Horiot JC. Rea-sons for irradiation failure in squamous cell carcinoma of the larynx. Laryngoscope 1975; 85: 987–1003.
   PubMed Web of Science ®Google Scholar
• Barkley HT Jr, Fletcher GH, Jesse RH, Lindberg RD. Man-agement of cervical lymph node metastases in squamous cell carcinoma of the tonsillar fossa, base of tongue, supraglottic larynx, and hypopharynx. Am J Surg 1972; 124: 462–7.
   PubMed Web of Science ®Google Scholar
• Fletcher GH, Jesse RH, Lindberg RD, Koons CR. The place of radiotherapy in the management of the squamous cell carcinoma of the supraglottic larynx. Am J Roentgenol Ra-dium Ther Nucl Med 1970; 108: 19–26.
   PubMed Web of Science ®Google Scholar
• Goepfert H, Zaren HA, Jesse RH, Lindberg R. Treatment of laryngeal carcinoma with conservative surgery and postopera-tive radiation therapy. Arch Otolaryngol 1978; 104: 576–8.
   PubMedGoogle Scholar
• Specht L, Lauritzen AF, Nordentoft AM, et al. Tumor cell concentration and tumor burden in relation to histopatho-logic subtype and other prognostic factors in early stage Hodgkin's disease. The Danish National Hodgkin Study Group. Cancer 1990; 65: 2594–601.
   Google Scholar
• Specht L. Tumour burden as the main indicator of prognosis in Hodgkin's disease. Eur J Cancer 1992; 28A: 1982–5.
   PubMed Web of Science ®Google Scholar
• Aass N, Klepp 0, Cavallin Stahl E, et al. Prognostic factors in unselected patients with non-seminomatous metastatic tes-ticular cancer: a multicenter experience. J Clin Oncol 1991; 9: 818–26.
   Google Scholar
• van den Bogaert W, van der Schueren E, Horiot JC, et al. The EORTC randomized trial on three fractions per day and misonidazole in advanced head and neck cancer: prognostic factors. Radiother Oncol 1995; 35: 100–6.
   PubMed Web of Science ®Google Scholar